These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 16033088)

  • 1. Serum selenium in head and neck cancer patients--a new marker of tumor activity?
    Büntzel J; Micke O; Glatzel M; Fröhlich D; Bruns F; Mücke R; Schönekaes KG
    Anticancer Res; 2005; 25(3A):1711-2. PubMed ID: 16033088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selenium substitution during radiotherapy of solid tumours - laboratory data from two observation studies in gynaecological and head and neck cancer patients.
    Büntzel J; Micke O; Kisters K; Bruns F; Glatzel M; Schönekaes K; Kundt G; Schäfer U; Mücke R
    Anticancer Res; 2010 May; 30(5):1783-6. PubMed ID: 20592379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc concentrations in serum during head and neck cancer progression.
    Büntzel J; Bruns F; Glatzel M; Garayev A; Mücke R; Kisters K; Schäfer U; Schönekaes K; Micke O
    Anticancer Res; 2007; 27(4A):1941-3. PubMed ID: 17649800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum nitric oxide levels in patients with head and neck squamous cell carcinoma.
    Kizilay A; Kalcioğlu MT; Ozuğurlu F; Ozyurt H; Aladağ I; Ozturan O; Akyol O
    Kulak Burun Bogaz Ihtis Derg; 2007; 17(3):148-51. PubMed ID: 17873505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
    Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
    Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated plasma glutathione peroxidase concentration in acute severe asthma: comparison with plasma glutathione peroxidase activity, selenium and malondialdehyde.
    Jacobson GA; Yee KC; Ng CH
    Scand J Clin Lab Invest; 2007; 67(4):423-30. PubMed ID: 17558897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH.
    Muecke R; Klotz T; Giedl J; Buentzel J; Kundt G; Kisters K; Prott FJ; Micke O
    Acta Oncol; 2009; 48(3):452-6. PubMed ID: 18855158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
    Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
    Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and tissue selenium levels in gastric cancer patients and correlation with CEA.
    Charalabopoulos K; Kotsalos A; Batistatou A; Charalabopoulos A; Peschos D; Vezyraki P; Kalfakakou V; Metsios A; Charalampopoulos A; Macheras A; Agnantis N; Evangelou A
    Anticancer Res; 2009 Aug; 29(8):3465-7. PubMed ID: 19661375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverse correlation between serum PGE2 and T classification in head and neck cancer.
    Hambek M; Baghi M; Wagenblast J; Schmitt J; Baumann H; Knecht R
    Head Neck; 2007 Mar; 29(3):244-8. PubMed ID: 17123309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of serum selenium levels on radiotherapy-related toxicity in patients undergoing radiotherapy for head and neck cancer.
    Eroglu C; Unal D; Cetin A; Orhan O; Sivgin S; Oztürk A
    Anticancer Res; 2012 Aug; 32(8):3587-90. PubMed ID: 22843950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of glycoproteins as prognosticators in head and neck malignancy.
    Bathi RJ; Nandimath K; Kannan N; Shetty P
    Indian J Dent Res; 2001; 12(2):93-9. PubMed ID: 11665403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma osteopontin is an independent prognostic marker for head and neck cancers.
    Petrik D; Lavori PW; Cao H; Zhu Y; Wong P; Christofferson E; Kaplan MJ; Pinto HA; Sutphin P; Koong AC; Giaccia AJ; Le QT
    J Clin Oncol; 2006 Nov; 24(33):5291-7. PubMed ID: 17114663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor size-dependent elevations of serum gangliosides in patients with head and neck carcinomas.
    Portoukalian J; David MJ; Shen X; Richard M; Dubreuil C
    Biochem Int; 1989 Apr; 18(4):759-65. PubMed ID: 2764976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new assay to screen for head and neck squamous cell carcinoma using the tumor marker metallopanstimulin.
    Lee WJ; Keefer K; Hollenbeak CS; Stack BC
    Otolaryngol Head Neck Surg; 2004 Oct; 131(4):466-71. PubMed ID: 15467619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum vascular endothelial growth factor as a predictive factor in metronomic (weekly) Paclitaxel treatment for advanced head and neck cancer.
    Caballero M; Grau JJ; Blanch JL; Domingo-Domenech J; Auge JM; Jimenez W; Bernal-Sprekelsen M
    Arch Otolaryngol Head Neck Surg; 2007 Nov; 133(11):1143-8. PubMed ID: 18025320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of packed red cell transfusions on blood selenium concentration in pediatric hemato-oncology].
    Mackenroth J; Hölig K; Kuhlisch E; Siegert G; Suttorp M
    Klin Padiatr; 2008; 220(3):153-8. PubMed ID: 18478487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of telomerase expression in peripheral blood mononuclear cells of head and neck cancer patients.
    Lee BJ; Wang SG; Choi JS; Lee JC; Goh EK; Kim MG
    Am J Clin Oncol; 2006 Apr; 29(2):163-7. PubMed ID: 16601436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CD44v6 is not a sensitive tumor marker in patients with head and neck squamous cell cancer.
    Andratschke M; Chaubal S; Pauli C; Mack B; Hagedorn H; Wollenberg B
    Anticancer Res; 2005; 25(4):2821-6. PubMed ID: 16080532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum antioxidants and skin cancer risk: an 8-year community-based follow-up study.
    van der Pols JC; Heinen MM; Hughes MC; Ibiebele TI; Marks GC; Green AC
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1167-73. PubMed ID: 19336544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.